FDA issues warning advising consumers, health care professionals about drugs causing severe liver injury
The US Food and Drug Administration (FDA) issued a warning on Wednesday, May 26, advising consumers and health care professionals about potential rare occurrences of severe liver injury in patients taking the weight-loss medication orlistat, which is marketed by GlaxoSmithKline as Xenical and Alli. Xenical, which is available only by prescription, contains 120 milligrams of [Sign in to read the full article...]
